Femasys Launches FemCerv Endocervical Sampler, A Revolutionary Solution For Cervical Cancer Screening

ATLANTA, April 30, 2013 /PRNewswire/ -- Femasys Inc., a medical device developer of women's healthcare solutions, announced today the U.S. launch of the 510(k) cleared FemCerv™, an innovative endocervical curettage device.  FemCerv is designed to collect a complete,...